(Q37379177)

20 August 2017

1 reference

title

Insulin therapy in type 2 diabetes: what is the evidence? (English)

1 reference

20 August 2017

0 references

1 reference

1 reference

Mariëlle J P van Avendonk

series ordinal

1

1 reference

20 August 2017

Guy E H M Rutten

series ordinal

2

1 reference

20 August 2017

publication date

19 January 2009

1 reference

Diabetes, Obesity and Metabolism

20 August 2017

published in

1 reference

20 August 2017

volume

11

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

415-432

1 reference

Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00981.X

Crossref

reference URL

Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naïve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00981.X

Crossref

reference URL

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00981.X

Crossref

reference URL

10.1111/J.1463-1326.2008.00981.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference